Cargando…

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

HOXB13 is a prostate cancer susceptibility gene which shows a cancer predisposing (G84E) mutation in 0.1–0.6% of males. We analyzed the prognostic impact of HOXB13 expression by immunohistochemistry on a tissue microarray containing more than 12,400 prostate cancers. Results were compared to tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zabalza, Cristina Villares, Adam, Meike, Burdelski, Christoph, Wilczak, Waldemar, Wittmer, Corina, Kraft, Stefan, Krech, Till, Steurer, Stefan, Koop, Christina, Hube-Magg, Claudia, Graefen, Markus, Heinzer, Hans, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Tsourlakis, Maria Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494977/ https://www.ncbi.nlm.nih.gov/pubmed/25825985

Ejemplares similares

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2015)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
por: Tsourlakis, Maria Christina, et al.
Publicado: (2015)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2015)

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2017)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
por: Bonk, Sarah, et al.
Publicado: (2019)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

High mitochondria content is associated with prostate cancer disease progression
por: Grupp, Katharina, et al.
Publicado: (2013)

Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer
por: Burdelski, Christoph, et al.
Publicado: (2014)

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2017)

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2017)

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers()
por: Burdelski, Christoph, et al.
Publicado: (2017)

Deletion of 8p is an independent prognostic parameter in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

Deletion of 18q is a strong and independent prognostic feature in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

SNW1 is a prognostic biomarker in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer
por: JACOBSEN, FRANK, et al.
Publicado: (2013)

IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues
por: Burdelski, Christoph, et al.
Publicado: (2018)

Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
por: Heinrich, Marie-Christine, et al.
Publicado: (2018)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2017)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
por: Kluth, Martina, et al.
Publicado: (2018)

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer
por: Marx, Andreas, et al.
Publicado: (2020)

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019)

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
por: Bernreuther, Christian, et al.
Publicado: (2020)

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020)

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients
por: Tsourlakis, Maria-Christina, et al.
Publicado: (2016)

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019)

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
por: Jacobsen, Frank, et al.
Publicado: (2017)

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer
por: Freytag, Morton, et al.
Publicado: (2020)

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2017)

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
por: Marx, Andreas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aioh4gf6voq135fpntgvq4b7qs